<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153193">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02105090</url>
  </required_header>
  <id_info>
    <org_study_id>2012-005528-13</org_study_id>
    <nct_id>NCT02105090</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy</brief_title>
  <official_title>Comparison of Novel Articaine Lozenge Versus Placebo for Upper Gastrointestinal Endoscopy in Adults. A Randomized Double-blinded Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <authority>Finland: Finnish Medicines Agency</authority>
    <authority>Finland: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine in prospective, double-blinded randomised manner the
      ability of novel articaine-containing lozenge to enhance the procedure related compliance
      (compared to placebo) of the adult patients undergoing upper gastrointestinal endoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Percentage of participants with 15% change in tolerability points according to Visual Analogue Scale (compared to baseline Visual Analogue Scale).</measure>
    <time_frame>30 minutes after the procedure</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endoscopists´ procedural satisfaction points after the procedure assessed by using Visual Analogue Scale (VAS)</measure>
    <time_frame>within 30 minutes after the procedure</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative consumption of alfentanil during the procedure (mg)</measure>
    <time_frame>30 minutes after the procedure</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Dyspepsia</condition>
  <condition>Hematemesis</condition>
  <condition>Abdominal Pain</condition>
  <condition>Heartburn</condition>
  <arm_group>
    <arm_group_label>Sodium chloride 0.9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sodium chloride 0.9% flavoured lozenge 10 ml administered orally (gargled and swallowed by patient) 3 minutes before the upper GI endoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Articaine hydrochloride 1%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Articaine hydrochloride 1% flavoured lozenge 10 ml administered orally (gargled and swallowed by patient) 3 minutes before the upper GI endoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Articaine hydrochloride 2%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Articaine hydrochloride 2% flavoured lozenge 10 ml administered orally (gargled and swallowed by patient) 3 minutes before the upper GI endoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anesthetics, Local</intervention_name>
    <arm_group_label>Articaine hydrochloride 1%</arm_group_label>
    <arm_group_label>Articaine hydrochloride 2%</arm_group_label>
    <other_name>Ultracain D ohne Adrenalin 20 mg/ml, ATC code N01BB08</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Chloride 0.9%</intervention_name>
    <arm_group_label>Sodium chloride 0.9%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective procedure

          -  weight over 40 kg

          -  American Society of Anesthesiology class I-III

          -  first upper GI endoscopy procedure

          -  finnish or/and swedish speaking

        Exclusion Criteria:

          -  amide and/or esther local anaesthetic allergy

          -  paraben allergy

          -  Child-Pugh grade B/C liver failure

          -  renal insufficiency (calculated glomerular filtration rate under 60 ml/min/1.73 m2
             according to Cockcroft-Gault scale )

          -  dementia

          -  those presenting with swallowing problem

          -  chronic pain condition

          -  chronic use of pain medication

          -  pregnancy

          -  lactation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mihkel Meinberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Intensive care medicine, Division of Surgery, Meilahti Hospital, Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Reino Pöyhiä, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology and Intensive care medicine, Division of Surgery, Meilahti Hospital, Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mihkel Meinberg, MD</last_name>
    <phone>+358504286766</phone>
    <email>mihkel.meinberg@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reino Pöyhiä, MD, PhD</last_name>
    <phone>+35894711</phone>
    <email>reino.poyhia@hus.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive care medicine, Divison of Surgery, Meilahti hospital, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Campo R, Brullet E, Montserrat A, Calvet X, Moix J, Rué M, Roqué M, Donoso L, Bordas JM. Identification of factors that influence tolerance of upper gastrointestinal endoscopy. Eur J Gastroenterol Hepatol. 1999 Feb;11(2):201-4.</citation>
    <PMID>10102233</PMID>
  </reference>
  <reference>
    <citation>Davis DE, Jones MP, Kubik CM. Topical pharyngeal anesthesia does not improve upper gastrointestinal endoscopy in conscious sedated patients. Am J Gastroenterol. 1999 Jul;94(7):1853-6.</citation>
    <PMID>10406247</PMID>
  </reference>
  <reference>
    <citation>Shaoul R, Higaze H, Lavy A. Evaluation of topical pharyngeal anaesthesia by benzocaine lozenge for upper endoscopy. Aliment Pharmacol Ther. 2006 Aug 15;24(4):687-94.</citation>
    <PMID>16907901</PMID>
  </reference>
  <reference>
    <citation>Evans LT, Saberi S, Kim HM, Elta GH, Schoenfeld P. Pharyngeal anesthesia during sedated EGDs: is &quot;the spray&quot; beneficial? A meta-analysis and systematic review. Gastrointest Endosc. 2006 May;63(6):761-6. Review.</citation>
    <PMID>16650534</PMID>
  </reference>
  <reference>
    <citation>Asante MA, Northfield TC. Variation in taste of topical lignocaine anaesthesia for gastroscopy. Aliment Pharmacol Ther. 1998 Jul;12(7):685-6.</citation>
    <PMID>9701534</PMID>
  </reference>
  <reference>
    <citation>Mogensen S, Treldal C, Feldager E, Pulis S, Jacobsen J, Andersen O, Rasmussen M. New lidocaine lozenge as topical anesthesia compared to lidocaine viscous oral solution before upper gastrointestinal endoscopy. Local Reg Anesth. 2012;5:17-22. doi: 10.2147/LRA.S30715. Epub 2012 May 31.</citation>
    <PMID>22915898</PMID>
  </reference>
  <reference>
    <citation>Vree TB, Gielen MJ. Clinical pharmacology and the use of articaine for local and regional anaesthesia. Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):293-308. Review.</citation>
    <PMID>15966499</PMID>
  </reference>
  <reference>
    <citation>Brinklov MM. Clinical effects of carticaine, a new local anesthetic. A survey and a double-blind investigation comparing carticaine with lidocaine in epidural analgesia. Acta Anaesthesiol Scand. 1977;21(1):5-16.</citation>
    <PMID>320810</PMID>
  </reference>
  <reference>
    <citation>Kallio H, Snäll EV, Luode T, Rosenberg PH. Hyperbaric articaine for day-case spinal anaesthesia. Br J Anaesth. 2006 Nov;97(5):704-9. Epub 2006 Aug 5.</citation>
    <PMID>16891634</PMID>
  </reference>
  <reference>
    <citation>Pitkänen MT, Xu M, Haasio J, Rosenberg PH. Comparison of 0.5% articaine and 0.5% prilocaine in intravenous regional anesthesia of the arm: a cross-over study in volunteers. Reg Anesth Pain Med. 1999 Mar-Apr;24(2):131-5.</citation>
    <PMID>10204898</PMID>
  </reference>
  <reference>
    <citation>Simon MA, Vree TB, Gielen MJ, Booij LH, Lagerwerf AJ. Similar motor block effects with different disposition kinetics between lidocaine and (+ or -) articaine in patients undergoing axillary brachial plexus block during day case surgery. Int J Clin Pharmacol Ther. 1999 Dec;37(12):598-607.</citation>
    <PMID>10599952</PMID>
  </reference>
  <reference>
    <citation>Vree TB, Baars AM, van Oss GE, Booij LH. High-performance liquid chromatography and preliminary pharmacokinetics of articaine and its 2-carboxy metabolite in human serum and urine. J Chromatogr. 1988 Feb 26;424(2):440-4.</citation>
    <PMID>3372637</PMID>
  </reference>
  <reference>
    <citation>Prout BJ, Metreweli C. Pulmonary aspiration after fibre-endoscopy of the upper gastrointestinal tract. Br Med J. 1972 Nov 4;4(5835):269-71.</citation>
    <PMID>4343464</PMID>
  </reference>
  <reference>
    <citation>Oertel R, Rahn R, Kirch W. Clinical pharmacokinetics of articaine. Clin Pharmacokinet. 1997 Dec;33(6):417-25. Review.</citation>
    <PMID>9435991</PMID>
  </reference>
  <reference>
    <citation>Simon MA, Vree TB, Gielen MJ, Booij LH. Comparison of the effects and disposition kinetics of articaine and lidocaine in 20 patients undergoing intravenous regional anaesthesia during day case surgery. Pharm World Sci. 1998 Apr;20(2):88-92.</citation>
    <PMID>9584343</PMID>
  </reference>
  <reference>
    <citation>Alhashemi JA. Dexmedetomidine vs midazolam for monitored anaesthesia care during cataract surgery. Br J Anaesth. 2006 Jun;96(6):722-6. Epub 2006 Apr 4.</citation>
    <PMID>16595611</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 4, 2014</lastchanged_date>
  <firstreceived_date>March 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Mihkel Meinberg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Upper gastrointestinal tract</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Lozenge</keyword>
  <keyword>Articaine</keyword>
  <keyword>Dyspepsia</keyword>
  <keyword>Hematemesis</keyword>
  <keyword>Abdominal pain</keyword>
  <keyword>Heartburn</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Abdominal Pain</mesh_term>
    <mesh_term>Dyspepsia</mesh_term>
    <mesh_term>Heartburn</mesh_term>
    <mesh_term>Hematemesis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Carticaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
